DuPont de Nemours (NYSE:DD – Get Free Report) issued an update on its FY 2026 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 7.020-7.160 for the period, compared to the consensus earnings per share estimate of 7.170. The company issued revenue guidance of -. DuPont de Nemours also updated its Q2 2026 guidance to 1.750-1.750 EPS.
DuPont de Nemours Stock Performance
Shares of DuPont de Nemours stock opened at $46.67 on Wednesday. The company has a market capitalization of $18.90 billion, a PE ratio of -777.70, a PEG ratio of 1.37 and a beta of 1.03. DuPont de Nemours has a 12 month low of $28.07 and a 12 month high of $52.66. The company has a current ratio of 2.68, a quick ratio of 2.11 and a debt-to-equity ratio of 0.22. The stock’s fifty day simple moving average is $47.70 and its 200 day simple moving average is $45.83.
DuPont de Nemours (NYSE:DD – Get Free Report) last issued its quarterly earnings data on Tuesday, May 5th. The basic materials company reported $1.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.44 by $0.21. DuPont de Nemours had a positive return on equity of 7.15% and a negative net margin of 0.30%.The business had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same period in the previous year, the firm earned $3.09 EPS. DuPont de Nemours’s quarterly revenue was up 4.3% compared to the same quarter last year. DuPont de Nemours has set its Q2 2026 guidance at 0.590-0.590 EPS and its FY 2026 guidance at 2.350-2.400 EPS. On average, research analysts predict that DuPont de Nemours will post 2.38 EPS for the current year.
DuPont de Nemours Increases Dividend
Analyst Ratings Changes
DD has been the topic of several recent research reports. Morgan Stanley lifted their price target on DuPont de Nemours from $132.00 to $156.00 and gave the company an “equal weight” rating in a research note on Tuesday, April 28th. Royal Bank Of Canada upped their target price on DuPont de Nemours from $168.00 to $180.00 and gave the stock an “outperform” rating in a report on Monday, May 11th. The Goldman Sachs Group assumed coverage on DuPont de Nemours in a research report on Monday, June 15th. They set a “neutral” rating and a $159.00 price target for the company. Weiss Ratings raised DuPont de Nemours from a “sell (d)” rating to a “sell (d+)” rating in a research report on Wednesday, May 6th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on DuPont de Nemours from $174.00 to $180.00 and gave the stock a “buy” rating in a research note on Thursday, May 7th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $165.20.
View Our Latest Stock Analysis on DuPont de Nemours
Institutional Investors Weigh In On DuPont de Nemours
Several hedge funds have recently added to or reduced their stakes in DD. Palisade Asset Management LLC acquired a new position in shares of DuPont de Nemours in the third quarter valued at $26,000. Imprint Wealth LLC bought a new position in shares of DuPont de Nemours in the third quarter valued at about $27,000. Measured Wealth Private Client Group LLC acquired a new stake in shares of DuPont de Nemours during the 3rd quarter worth about $30,000. Atlas Capital Advisors Inc. bought a new stake in shares of DuPont de Nemours during the 4th quarter worth about $38,000. Finally, Ameriflex Group Inc. boosted its holdings in shares of DuPont de Nemours by 5,940.0% during the 4th quarter. Ameriflex Group Inc. now owns 1,208 shares of the basic materials company’s stock worth $49,000 after buying an additional 1,188 shares during the period. Institutional investors and hedge funds own 73.96% of the company’s stock.
DuPont de Nemours Company Profile
DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.
DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.
Featured Articles
- Five stocks we like better than DuPont de Nemours
- Why nVent Could Be a Long-Term AI Infrastructure Winner
- Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
- Apple’s Intel Deal Arrives at the Right Time for Its Stock
- Liquid Gold: The AI Cooling Retrofit Trade
Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.
